Acorah Software Products - Accounts Production 19.3.600 false true true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 12570428 R Prasad S K Guha N Bhatnagar true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12570428 2025-03-31 12570428 2026-03-31 12570428 2025-04-01 2026-03-31 12570428 frs-core:CurrentFinancialInstruments 2026-03-31 12570428 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2026-03-31 12570428 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2025-04-01 2026-03-31 12570428 frs-core:CopyrightsPatentsTrademarksServiceOperatingRights 2025-03-31 12570428 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2026-03-31 12570428 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-01 2026-03-31 12570428 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 12570428 frs-core:FurnitureFittings 2026-03-31 12570428 frs-core:FurnitureFittings 2025-04-01 2026-03-31 12570428 frs-core:FurnitureFittings 2025-03-31 12570428 frs-core:OtherResidualIntangibleAssets 2026-03-31 12570428 frs-core:OtherResidualIntangibleAssets 2025-04-01 2026-03-31 12570428 frs-core:OtherResidualIntangibleAssets 2025-03-31 12570428 frs-core:PlantMachinery 2026-03-31 12570428 frs-core:PlantMachinery 2025-04-01 2026-03-31 12570428 frs-core:PlantMachinery 2025-03-31 12570428 frs-core:WithinOneYear 2026-03-31 12570428 frs-core:SharePremium 2026-03-31 12570428 frs-core:ShareCapital 2026-03-31 12570428 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 12570428 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 12570428 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 12570428 frs-bus:SmallEntities 2025-04-01 2026-03-31 12570428 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 12570428 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 12570428 1 2025-04-01 2026-03-31 12570428 frs-bus:Director1 2025-04-01 2026-03-31 12570428 frs-bus:Director2 2025-04-01 2026-03-31 12570428 frs-bus:Director3 2025-04-01 2026-03-31 12570428 frs-countries:EnglandWales 2025-04-01 2026-03-31 12570428 2024-03-31 12570428 2025-03-31 12570428 2024-04-01 2025-03-31 12570428 frs-core:CurrentFinancialInstruments 2025-03-31 12570428 frs-core:WithinOneYear 2025-03-31 12570428 frs-core:SharePremium 2025-03-31 12570428 frs-core:ShareCapital 2025-03-31 12570428 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31
Registered number: 12570428
Almora Botanica UK Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2026
Finerva
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 12570428
2026 2025
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 177,518 278,482
Tangible Assets 5 12,021 13,983
189,539 292,465
CURRENT ASSETS
Stocks 6 386,242 516,589
Debtors 7 380,619 133,247
Cash at bank and in hand 675,353 149,727
1,442,214 799,563
Creditors: Amounts Falling Due Within One Year 8 (295,526 ) (353,415 )
NET CURRENT ASSETS (LIABILITIES) 1,146,688 446,148
TOTAL ASSETS LESS CURRENT LIABILITIES 1,336,227 738,613
NET ASSETS 1,336,227 738,613
CAPITAL AND RESERVES
Called up share capital 9 1,666 1,506
Share premium account 8,740,065 6,587,791
Profit and Loss Account (7,405,504 ) (5,850,684 )
SHAREHOLDERS' FUNDS 1,336,227 738,613
Page 1
Page 2
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
R Prasad
Director
19 October 2026
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Almora Botanica UK Ltd is a private company,  limited by shares, incorporated in England & Wales, registered number 12570428 . The registered office is C/O Browne Jacobson Llp, 15th Floor, 6 Bevis Marks , London, EC3A 7BA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in  accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The company’s financial statements have been prepared on a going concern basis on the grounds  that current and future sources of funding or support will be more than adequate for the company’s needs. In assessing going concern, the directors have a reasonable expectation that the company will continue as a going concern and is able to meet all of its obligations as they fall due for a minimum of 12 months from the date of approval of these financial statements.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the  significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
2.4. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. 
The  capitalised development costs relate to product development and to website development.  
They are  amortised to profit and loss account on a straight line basis over their expected useful economic lives of 5 years.
If it is not possible to distinguish between the research phase and the development phase of  an internal project the expenditure is treated as if it were all incurred in the research phase only.
2.5. Intangible Fixed Assets and Amortisation - Intellectual Property
Intellectual property assets are trademarks and patents. 
They are amortised to the profit and loss account over their estimated economic life  of 5-10 years.
2.6. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.  Depreciation  is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 33% straight line
Fixtures & Fittings 33% straight line
2.7. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.   Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. 
Page 3
Page 4
2.8. Financial Instruments
Trade and other debtors / creditors
Trade and other debtors are recognised initially at transaction prices less attributable transaction costs. Trade and other creditors are recognised initially at transaction price plus attributable transaction costs. Subsequent to initial recognition they are measured at amortised cost using the effective interest method, less any impairment losses in the case of trade debtors. If the arrangement constitutes a financing transaction, for example if payment is deferred beyond normal business terms, then it is measured at the present value of future payments discounted at a market rate of interest for a similar debt instrument.
Impairment of financial assets
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found an impairment loss is recognised within profit or loss.
For financial assets that are measured at amortised cost, the impairment loss is measured as the difference between the asset’s carrying amount and the present value of estimated cash flows discounted at the asset’s original effective interest rate.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between the asset’s carrying amount and the best estimate of the amount that the company would receive for the asset if it were to be sold at the balance sheet date.
2.9. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date.   Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
2.10. Related party exemption
The company has taken advantage of the exemption available under FRS 102 not to disclose related party transactions with wholly owned subsidiaries in the group.
3. Average Number of Employees
Average number of employees, including directors, during the year was as follows: NIL (2025: 1)
- 1
4. Intangible Assets
Product Development Website Development Intellectual Property Total
£ £ £ £
Cost
As at 1 April 2025 497,118 89,682 51,266 638,066
Additions 5,463 3,080 17,605 26,148
As at 31 March 2026 502,581 92,762 68,871 664,214
Amortisation
As at 1 April 2025 314,397 29,099 16,088 359,584
Provided during the period 99,980 18,015 9,117 127,112
As at 31 March 2026 414,377 47,114 25,205 486,696
Net Book Value
As at 31 March 2026 88,204 45,648 43,666 177,518
As at 1 April 2025 182,721 60,583 35,178 278,482
Page 4
Page 5
5. Tangible Assets
Plant & Machinery Fixtures & Fittings Total
£ £ £
Cost
As at 1 April 2025 8,661 20,973 29,634
As at 31 March 2026 8,661 20,973 29,634
Depreciation
As at 1 April 2025 7,507 8,144 15,651
Provided during the period 541 1,421 1,962
As at 31 March 2026 8,048 9,565 17,613
Net Book Value
As at 31 March 2026 613 11,408 12,021
As at 1 April 2025 1,154 12,829 13,983
6. Stocks
2026 2025
£ £
Stock 386,242 516,589
7. Debtors
2026 2025
£ £
Due within one year
Trade debtors 79,287 18,277
Amounts owed by group undertakings 234,137 39,030
Other debtors 67,195 75,940
380,619 133,247
8. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Trade creditors 53,509 116,785
Other creditors 242,017 236,630
295,526 353,415
9. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 1,666 1,506
Page 5
Page 6
10. Other Commitments
The total of future minimum lease payments under non-cancellable operating leases are as following:
2026 2025
£ £
Not later than one year 2,746 4,875
2,746 4,875
11. Related Party Transactions
At 31 March 2026, the company owed £27,651 (2025: £Nil) to its parent company, Almora Botanica Global Holdings Limited. 
12. Ultimate Parent Undertaking and Controlling Party
The company's immediate parent undertaking is Almora Botanica Global Holdings Limited . Almora Botanica Global Holdings Limited was incorporated in England & Wales. Group accounts are not prepared.
Page 6